[Not Available].
作者信息
Daniel C
机构信息
Département innovation et données, direction des systèmes d'information, AP-HP, 33, boulevard de Picpus, 75012 Paris, France; Sorbonne université, université Paris 13, Sorbonne Paris Cité, Inserm UMR_S 1142, LIMICS, Paris, France.
出版信息
Rev Med Interne. 2020 May;41(5):303-307. doi: 10.1016/j.revmed.2020.04.005. Epub 2020 Apr 17.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Rev Med Interne. 2020 May;41(5):303-307. doi: 10.1016/j.revmed.2020.04.005. Epub 2020 Apr 17.
2
[Medecine by ordeal].[神判医学]
J Fr Ophtalmol. 2020 May;43(5):377-378. doi: 10.1016/j.jfo.2020.04.007. Epub 2020 Apr 18.
3
Strategies for Resiliency of Medical Staff During COVID-19.新冠疫情期间医护人员的心理调适策略
Mayo Clin Proc. 2020 Sep;95(9S):S56-S59. doi: 10.1016/j.mayocp.2020.07.002. Epub 2020 Aug 17.
4
The Landscape of Medical Literature in the Era of COVID-19: Original Research Versus Opinion Pieces.新冠疫情时代的医学文献格局：原创研究与观点文章
J Gen Intern Med. 2020 Sep;35(9):2813-2815. doi: 10.1007/s11606-020-06021-8. Epub 2020 Jul 8.
5
[Not Available].[无可用内容]
Rev Med Interne. 2020 May;41(5):301-302. doi: 10.1016/j.revmed.2020.04.003. Epub 2020 Apr 17.
6
Supporting the UK National Health Service during the COVID-19 crisis from an academic perspective.从学术角度在新冠疫情危机期间支持英国国民医疗服务体系。
Nat Med. 2020 Jul;26(7):989. doi: 10.1038/s41591-020-0885-5.
7
Covid-19: First severe pandemic of the 21st century.新冠疫情：21世纪的首场严重大流行病。
Tunis Med. 2020 Apr;98(4):255-257.
8
The urgent need for integrated science to fight COVID-19 pandemic and beyond.应对新冠疫情等紧急情况需要综合科学。
J Transl Med. 2020 May 19;18(1):205. doi: 10.1186/s12967-020-02364-2.
9
Research Response to SARS-CoV-2/COVID-19.对严重急性呼吸综合征冠状病毒2/2019冠状病毒病的研究应对措施
Mayo Clin Proc. 2020 Sep;95(9S):S52-S55. doi: 10.1016/j.mayocp.2020.06.048. Epub 2020 Jul 7.
10
Q&A: Preparing for Pandemic, An Interview with Umair Shah, MD, Harris County Public Health.问答：为大流行做准备，对哈里斯县公共卫生部门的医学博士乌迈尔·沙阿的采访。
Tex Med. 2020 Jun 1;116(6):27-28.
引用本文的文献
1
New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown.SARS-CoV-2 大流行期间新发癌症病例和相关公共卫生政策：全国封锁结束很久后持续且令人担忧的下降。
Eur J Cancer. 2021 Jun;150:260-267. doi: 10.1016/j.ejca.2021.02.015. Epub 2021 Feb 25.
本文引用的文献
1
Rapid response to COVID-19: health informatics support for outbreak management in an academic health system.快速应对 COVID-19：在学术医疗系统中，健康信息学为疫情管理提供支持。
J Am Med Inform Assoc. 2020 Jun 1;27(6):853-859. doi: 10.1093/jamia/ocaa037.
2
Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts.高血压一线双联联合治疗的比较：来自多国异质性队列的真实世界证据
Korean Circ J. 2020 Jan;50(1):52-68. doi: 10.4070/kcj.2019.0173. Epub 2019 Aug 28.
3
Evaluative Outcomes in Direct Extraction and Use of EHR Data in Clinical Trials.临床试验中电子健康记录（EHR）数据的直接提取与使用中的评估结果。
Stud Health Technol Inform. 2019;257:333-340.
4
eSource for Standardized Health Information Exchange in Clinical Research: A Systematic Review.临床研究中标准化健康信息交换的电子源：一项系统综述。
Stud Health Technol Inform. 2019;257:115-124.
5
Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations.利用真实世界数据的联邦网络优化临床试验运营。
JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00067.
6
CancerLinQ: Origins, Implementation, and Future Directions.癌症LinQ：起源、实施及未来方向。
JCO Clin Cancer Inform. 2018 Dec;2:1-7. doi: 10.1200/CCI.17.00060.
7
Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platform.支持临床试验方案优化的联合电子健康记录研究技术：来自EHR4CR和InSite平台的证据。
J Biomed Inform. 2019 Feb;90:103090. doi: 10.1016/j.jbi.2018.12.004. Epub 2019 Jan 2.
8
Initializing a hospital-wide data quality program. The AP-HP experience.启动全院范围的数据质量计划。AP-HP 的经验。
Comput Methods Programs Biomed. 2019 Nov;181:104804. doi: 10.1016/j.cmpb.2018.10.016. Epub 2018 Nov 9.
9
Real-world evidence research based on big data: Motivation-challenges-success factors.基于大数据的真实世界证据研究：动机、挑战与成功因素
Onkologe (Berl). 2018;24(Suppl 2):91-98. doi: 10.1007/s00761-018-0358-3. Epub 2018 Jun 7.
10
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.治疗和/或比较效果的真实世界数据研究的良好实践：ISPOR-ISPE联合特别工作组关于医疗保健决策中真实世界证据的建议。
Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1033-1039. doi: 10.1002/pds.4297.
Zotero 插件